Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis

Medical Mycology

Volumn 44, Issue 7, 2006, Pages 611-615

  Eraso, Elena ^a   Sahand, Ismail H ^a   Villar Vidal, María ^a   Marcos, Cristina ^a   Dolores Moragues, María ^a   Madariaga, Lucila ^a   Pontón, José ^a   Quindós, Guillermo ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Candida albicans; Candida dubliniensis; Candida ID2; CHROMagar candida; Chromogenic agar; Identification

Indexed keywords

AGAR MEDIUM; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; COLOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; INTERMETHOD COMPARISON; NONHUMAN; ORGANISM COLONY; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENTIATION;

AGAR; CANDIDA; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; MYCOLOGICAL TYPING TECHNIQUES; SPECIES SPECIFICITY;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS;

EID: 33750473697     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780600830691     Document Type: Article

References (30)

1. Gutiérrez, J and Morales, P and González, M A and (2002) Candida dubliniensis, a new fungal pathogen J Basic Microbiol, 42, pp. 207-227.
2. Sullivan, D J and Moran, G P and Pinjon, E and (2004) Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans FEMS Yeast Res, 4, pp. 369-376.
3. Binolfi, A and Biasoli, M S and Luque, A G and (2005) High prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina Med Mycol, 43, pp. 431-437.
4. Kalkanci, A and Kokturk, N and Senol, E and (2005) Could Candida dubliniensis be involved in lung fungus balls? Rev Iberoam Micol, 22, pp. 157-159.
5. Jabra-Rizk, M A and Johnson, J K and Forrest, G and (2005) Prevalence of Candida dubliniensis fungemia at a large teaching hospital Clin Infect Dis, 41, pp. 1064-1067.
6. Tortorano, A M and Peman, J and Bernhardt, H and (2004) Epidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study Eur J Clin Microbiol Infect Dis, 23, pp. 317-322.
7. Pfaller, M A and Messer, S A and Gee, S and (1999) In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents J Clin Microbiol, 37, pp. 870-872.
8. Quindós, G and Carrillo-Muǹoz, A J and Arévalo, M P and (2000) In vitro susceptibility of Candida dubliniensis to current and new antifungal agents Chemotherapy, 46, pp. 395-401.
9. Quindós, G and Ruesga, M T and Martín-Mazuelos, E and (2004) In vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts Rev Iberoam Micol, 21, pp. 63-69.
10. Al Mosaid, A and Sullivan, D J and Polacheck, I and (2005) Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting J Clin Microbiol, 43, pp. 4026-4036.
11. Moran, G P and Sanglard, D and Donnelly, S M and (1998) Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis Antimicrob Agents Chemother, 42, pp. 1819-1830.
12. Pinjon, E and Sullivan, D and Salkin, I and Shanley, D and Coleman, D. (1998) Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans J Clin Microbiol, 36, pp. 2093-2095.
13. Staib, P and Morschhauser, J. (1999) Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis Mycoses, 42, pp. 521-524.
14. Sahand, I H and Moragues, M D and Eraso, E and (2005) Supplementation of CHROMagar Candida medium with Pal's medium for rapid identification of Candida dubliniensis J Clin Microbiol, 43, pp. 5768-5770.
15. Jabra-Rizk, M A and Brenner, T M and Romagnoli, M and (2001) Evaluation of a reformulated CHROMagar Candida J Clin Microbiol, 39, pp. 2015-2016.
16. Bikandi, J and San Millán, R and Moragues, M D and (1998) Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes J Clin Microbiol, 36, pp. 2428-2433.
17. Brena, S and Rubio, M C and Salesa, R and (2003) Genotipos de Candida dubliniensis en aislamientos clinicos Rev Iberoam Micol, 21, pp. 20-23.
18. Kanbe, T and Horii, T and Arishima, T and Ozeki, M and (2002) PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes Yeast, 19, pp. 973-989.
19. Cárdenes-Perera, C D and Torres-Lana, A and Alonso-Vargas, R and (2004) Evaluation of API ID 32C and VITEK-2 to identify Candida dubliniensis Diagn Microbiol Infect Dis, 50, pp. 219-221.
20. Al Mosaid, A and Sullivan, D J and Coleman, D C. (2003) Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar J Clin Microbiol, 41, pp. 4787-4789.
21. Mosca, C O and Moragues, M D and Llovo, J and (2003) Casein agar: A useful medium for differentiating Candida dubliniensis from Candida albicans J Clin Microbiol, 41, pp. 1259-1262.
22. Kumar, C P and Menon, T. (2005) Tobacco agar: A new medium for chlamydosporulation in Candida albicans and Candida dubliniensis Med Mycol, 43, pp. 473-475.
23. Alves S H, Linares C E, Loreto E S,. Utilization of tomato juice agar (V8 agar) in the presumptive identification of Candida dubliniensis. Rev Soc Bras Med Trop 2006; 39: 92-93. [In Portuguese].
24. Marot-Leblond, A and Beucher, B and David, S and (2006) Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies J Clin Microbiol, 44, pp. 138-142.
25. Sahand, I H and Moragues, M D and Robert, R and (2006) Evaluation of Bichro-Dubli Fumouze to distinguish Candida dubliniensis from Candida albicans Diagn Microbiol Infect Dis, 55, pp. 165-167.
26. Alonso-Vargas, R and Garaizar, J and Pontón, J and (2000) Utilidad de la amplificación aleatoria de ADN en la diferenciación de Candida albicans y Candida dubliniensis Rev Iberoam Micol, 17, pp. 10-13.
27. Kanbe, T and Kurimoto, K and Hattori, H and (2005) Rapid identification of Candida albicans and its related species Candida stellatoidea and Candida dubliniensis by a single PCR amplification using primers specific for the repetitive sequence (RPS) of Candida albicans J Dermatol Sci, 40, pp. 43-50.
28. Kirkpatrick, W R and Revankar, S G and McAtee, R K and (1998) Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates J Clin Microbiol, 36, pp. 3007-3012.
29. Hospenthal D R, Beckius M L, Floyd K L,. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob 2006; 5: 1. Available online at http://www.ann-clinmicrob.com/ content/5/1/1 (accessed on 13 January 2006).
30. Schoofs, A and Odds, FC and Colebunders, R and (1997) Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes Antimicrob Agents Chemother, 41, pp. 1625-1635.